Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7DDZ

The Crystal Structure of Human Neuropeptide Y Y2 Receptor with JNJ-31020028

Summary for 7DDZ
Entry DOI10.2210/pdb7ddz/pdb
DescriptorHuman Neuropeptide Y Y2 Receptor fusion protein, ~{N}-[4-[4-[(1~{S})-2-(diethylamino)-2-oxidanylidene-1-phenyl-ethyl]piperazin-1-yl]-3-fluoranyl-phenyl]-2-pyridin-3-yl-benzamide, FLAVIN MONONUCLEOTIDE (3 entities in total)
Functional Keywordsneuropeptide y y2 receptor, membrane protein
Biological sourceEnterobacteria phage RB59
More
Total number of polymer chains1
Total formula weight75307.32
Authors
Tang, T.,Han, S.,Zhao, Q.,Wu, B. (deposition date: 2020-10-30, release date: 2021-01-27, Last modification date: 2024-10-16)
Primary citationTang, T.,Hartig, C.,Chen, Q.,Zhao, W.,Kaiser, A.,Zhang, X.,Zhang, H.,Qu, H.,Yi, C.,Ma, L.,Han, S.,Zhao, Q.,Beck-Sickinger, A.G.,Wu, B.
Structural basis for ligand recognition of the neuropeptide Y Y 2 receptor.
Nat Commun, 12:737-737, 2021
Cited by
PubMed Abstract: The human neuropeptide Y (NPY) Y receptor (YR) plays essential roles in food intake, bone formation and mood regulation, and has been considered an important drug target for obesity and anxiety. However, development of drugs targeting YR remains challenging with no success in clinical application yet. Here, we report the crystal structure of YR bound to a selective antagonist JNJ-31020028 at 2.8 Å resolution. The structure reveals molecular details of the ligand-binding mode of YR. Combined with mutagenesis studies, the YR structure provides insights into key factors that define antagonistic activity of diverse antagonists. Comparison with the previously determined antagonist-bound YR structures identified receptor-ligand interactions that play different roles in modulating receptor activation and mediating ligand selectivity. These findings deepen our understanding about molecular mechanisms of ligand recognition and subtype specificity of NPY receptors, and would enable structure-based drug design.
PubMed: 33531491
DOI: 10.1038/s41467-021-21030-9
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.8 Å)
Structure validation

236620

PDB entries from 2025-05-28

PDB statisticsPDBj update infoContact PDBjnumon